Andrew Stewart - Publications
Affiliations: | Diabetes Obesity Metabolism Institute | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2017 | Sacaan AI, Thibault S, Hong M, Kondegowda NG, Nichols TC, Li R, Rosselot C, Evering W, Fenutria R, Vitsky A, Brown T, Finkelstein MB, Garcia-Ocaña A, Khan NK, Stewart AF, et al. CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats. Molecular Cancer Research : McR. PMID 28760782 DOI: 10.1158/1541-7786.MCR-17-0172 | 0.484 | |||
2015 | Wang P, Alvarez-Perez JC, Felsenfeld DP, Liu H, Sivendran S, Bender A, Kumar A, Sanchez R, Scott DK, Garcia-Ocaña A, Stewart AF. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nature Medicine. 21: 383-8. PMID 25751815 DOI: 10.1038/Nm.3820 | 0.307 | |||
2007 | Vasavada RC, Cozar-Castellano I, Sipula D, Stewart AF. Tissue-specific deletion of the retinoblastoma protein in the pancreatic beta-cell has limited effects on beta-cell replication, mass, and function. Diabetes. 56: 57-64. PMID 17192465 DOI: 10.2337/db06-0517 | 0.302 | |||
2006 | Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocaña A, Vasavada R, Stewart AF. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocrine Reviews. 27: 356-70. PMID 16638909 DOI: 10.1210/er.2006-0004 | 0.307 | |||
Show low-probability matches. |